News: Infectious Diseases

According to a new review in the journal Science, when highly social animals — such as ants, mice and bats — get sick, their social interactions change...

For the first time, scientists identified a critical mechanism that remdesivir uses against SARS-CoV-2 and unearthed information that drug companies can use to develop new...

The virus that causes the coronavirus disease COVID-19 is accumulating genetic mutations, one of which may have made it more contagious.

A new study shows how much more likely construction workers are to get diagnosed with COVID-19 compared to non-construction workers

An epidemiologist and two molecular bioscientists get to the bottom of your burning COVID-19 questions.

Discovery may aid the fight against antibiotic resistance.

An experimental COVID-19 vaccine against SARS-CoV-2 elicits neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered spike protein.

A redesigned version of the coronavirus spike protein called HexaPro might speed up vaccine production and yield a more effective immune response to SARS-CoV-2.

Finding offers important clues to developing drugs to stop other RNA viruses, such as SARS-COV-2.

The COVID-19 vaccine was only possible because a group of scientists and their partners in industry had already invested years in laying the groundwork.